Stock Events

Stock Events

Search...

Ultragenyx Pharmaceutical (RARE) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.66

-1.54

-1.43

-1.31

Details

Expected EPS

-1.597778

Actual EPS

-1.57

Surprise EPS

0.03

Surprise Percent

+1.74%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.57 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.